Korro Bio, Inc.(KRRO)

盘后68.150.000.00%16:01 EDT

68.15+0.02+0.03%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Korro Bio, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://korrobio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Korro Bio, Inc.是一家特拉华州公司。Korro Bio是一家生物制药公司，其使命是发现、开发和商业化一种基于编辑RNA的新型基因药物，从而能够治疗罕见和高度流行的疾病。Korro Bio正在开发一系列差异化程序，旨在利用人体的自然RNA编辑过程，实现精确而短暂的单碱基编辑。
- 10-17
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 10-16
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 09-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-30
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 08-28
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-13
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 07-12
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 06-21
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-20
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 05-14
  招股说明书
  Form S-1 - General form for registration of securities under the Securities Act of 1933
  Form S-1 - General form for registration of securities under the Securities Act of 1933
- 05-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]